世界の多発性骨髄腫治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Multiple Myeloma Therapy Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5872
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、106ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、多発性骨髄腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（標的療法、化学療法、放射線療法、骨髄移植、その他）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・多発性骨髄腫治療の市場動向
・企業の競争状況、市場シェア
・多発性骨髄腫治療の種類別市場規模と予測2016-2027（標的療法、化学療法、放射線療法、骨髄移植、その他）
・多発性骨髄腫治療の用途別市場規模と予測2016-2027（病院、クリニック）
・多発性骨髄腫治療の北米市場規模2016-2027（アメリカ、カナダ）
・多発性骨髄腫治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・多発性骨髄腫治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・多発性骨髄腫治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・多発性骨髄腫治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Sanofi、Celgene、Johnson & Johnson、GlaxoSmithKline plc、F. Hoffmann-La Roche Ltd、AbbVie Inc.、Amgen Inc.、Novartis AG、Millennium Pharmaceuticals、Innate Pharma SA）
・結論

Multiple myeloma or plasma cell myeloma is a form of cancer of the plasma cells. In this condition, the body produces abnormal plasma cells which collect near the bone marrow and hamper normal functioning of the healthy plasma cells.

Market Analysis and Insights: Global Multiple Myeloma Therapy Market
The global Multiple Myeloma Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Multiple Myeloma Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Multiple Myeloma Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Multiple Myeloma Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Multiple Myeloma Therapy market.

Global Multiple Myeloma Therapy Scope and Market Size
Multiple Myeloma Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Multiple Myeloma Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Targeted Therapy
Chemotherapy
Radiotherapy
Bone Marrow Transplant
Others

Segment by Application
Hospital
Clinic

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Sanofi
Celgene
Johnson & Johnson
GlaxoSmithKline plc
F. Hoffmann-La Roche Ltd
AbbVie Inc.
Amgen Inc.
Novartis AG
Millennium Pharmaceuticals
Innate Pharma SA

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multiple Myeloma Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Targeted Therapy
1.2.3 Chemotherapy
1.2.4 Radiotherapy
1.2.5 Bone Marrow Transplant
1.2.6 Others
1.3 Market by Application
1.3.1 Global Multiple Myeloma Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Multiple Myeloma Therapy Market Perspective (2016-2027)
2.2 Multiple Myeloma Therapy Growth Trends by Regions
2.2.1 Multiple Myeloma Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Multiple Myeloma Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Multiple Myeloma Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Multiple Myeloma Therapy Industry Dynamic
2.3.1 Multiple Myeloma Therapy Market Trends
2.3.2 Multiple Myeloma Therapy Market Drivers
2.3.3 Multiple Myeloma Therapy Market Challenges
2.3.4 Multiple Myeloma Therapy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Multiple Myeloma Therapy Players by Revenue
3.1.1 Global Top Multiple Myeloma Therapy Players by Revenue (2016-2021)
3.1.2 Global Multiple Myeloma Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Multiple Myeloma Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Multiple Myeloma Therapy Revenue
3.4 Global Multiple Myeloma Therapy Market Concentration Ratio
3.4.1 Global Multiple Myeloma Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multiple Myeloma Therapy Revenue in 2020
3.5 Multiple Myeloma Therapy Key Players Head office and Area Served
3.6 Key Players Multiple Myeloma Therapy Product Solution and Service
3.7 Date of Enter into Multiple Myeloma Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Multiple Myeloma Therapy Breakdown Data by Type
4.1 Global Multiple Myeloma Therapy Historic Market Size by Type (2016-2021)
4.2 Global Multiple Myeloma Therapy Forecasted Market Size by Type (2022-2027)

5 Multiple Myeloma Therapy Breakdown Data by Application
5.1 Global Multiple Myeloma Therapy Historic Market Size by Application (2016-2021)
5.2 Global Multiple Myeloma Therapy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Multiple Myeloma Therapy Market Size (2016-2027)
6.2 North America Multiple Myeloma Therapy Market Size by Type
6.2.1 North America Multiple Myeloma Therapy Market Size by Type (2016-2021)
6.2.2 North America Multiple Myeloma Therapy Market Size by Type (2022-2027)
6.2.3 North America Multiple Myeloma Therapy Market Size by Type (2016-2027)
6.3 North America Multiple Myeloma Therapy Market Size by Application
6.3.1 North America Multiple Myeloma Therapy Market Size by Application (2016-2021)
6.3.2 North America Multiple Myeloma Therapy Market Size by Application (2022-2027)
6.3.3 North America Multiple Myeloma Therapy Market Size by Application (2016-2027)
6.4 North America Multiple Myeloma Therapy Market Size by Country
6.4.1 North America Multiple Myeloma Therapy Market Size by Country (2016-2021)
6.4.2 North America Multiple Myeloma Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Multiple Myeloma Therapy Market Size (2016-2027)
7.2 Europe Multiple Myeloma Therapy Market Size by Type
7.2.1 Europe Multiple Myeloma Therapy Market Size by Type (2016-2021)
7.2.2 Europe Multiple Myeloma Therapy Market Size by Type (2022-2027)
7.2.3 Europe Multiple Myeloma Therapy Market Size by Type (2016-2027)
7.3 Europe Multiple Myeloma Therapy Market Size by Application
7.3.1 Europe Multiple Myeloma Therapy Market Size by Application (2016-2021)
7.3.2 Europe Multiple Myeloma Therapy Market Size by Application (2022-2027)
7.3.3 Europe Multiple Myeloma Therapy Market Size by Application (2016-2027)
7.4 Europe Multiple Myeloma Therapy Market Size by Country
7.4.1 Europe Multiple Myeloma Therapy Market Size by Country (2016-2021)
7.4.2 Europe Multiple Myeloma Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Multiple Myeloma Therapy Market Size (2016-2027)
8.2 Asia-Pacific Multiple Myeloma Therapy Market Size by Type
8.2.1 Asia-Pacific Multiple Myeloma Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Multiple Myeloma Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Multiple Myeloma Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Multiple Myeloma Therapy Market Size by Application
8.3.1 Asia-Pacific Multiple Myeloma Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Multiple Myeloma Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Multiple Myeloma Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Multiple Myeloma Therapy Market Size by Region
8.4.1 Asia-Pacific Multiple Myeloma Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Multiple Myeloma Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Multiple Myeloma Therapy Market Size (2016-2027)
9.2 Latin America Multiple Myeloma Therapy Market Size by Type
9.2.1 Latin America Multiple Myeloma Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Multiple Myeloma Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Multiple Myeloma Therapy Market Size by Type (2016-2027)
9.3 Latin America Multiple Myeloma Therapy Market Size by Application
9.3.1 Latin America Multiple Myeloma Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Multiple Myeloma Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Multiple Myeloma Therapy Market Size by Application (2016-2027)
9.4 Latin America Multiple Myeloma Therapy Market Size by Country
9.4.1 Latin America Multiple Myeloma Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Multiple Myeloma Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Multiple Myeloma Therapy Market Size (2016-2027)
10.2 Middle East & Africa Multiple Myeloma Therapy Market Size by Type
10.2.1 Middle East & Africa Multiple Myeloma Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Multiple Myeloma Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Multiple Myeloma Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Multiple Myeloma Therapy Market Size by Application
10.3.1 Middle East & Africa Multiple Myeloma Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Multiple Myeloma Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Multiple Myeloma Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Multiple Myeloma Therapy Market Size by Country
10.4.1 Middle East & Africa Multiple Myeloma Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Multiple Myeloma Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Multiple Myeloma Therapy Introduction
11.1.4 Sanofi Revenue in Multiple Myeloma Therapy Business (2016-2021)
11.1.5 Sanofi Recent Development
11.2 Celgene
11.2.1 Celgene Company Details
11.2.2 Celgene Business Overview
11.2.3 Celgene Multiple Myeloma Therapy Introduction
11.2.4 Celgene Revenue in Multiple Myeloma Therapy Business (2016-2021)
11.2.5 Celgene Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Multiple Myeloma Therapy Introduction
11.3.4 Johnson & Johnson Revenue in Multiple Myeloma Therapy Business (2016-2021)
11.3.5 Johnson & Johnson Recent Development
11.4 GlaxoSmithKline plc
11.4.1 GlaxoSmithKline plc Company Details
11.4.2 GlaxoSmithKline plc Business Overview
11.4.3 GlaxoSmithKline plc Multiple Myeloma Therapy Introduction
11.4.4 GlaxoSmithKline plc Revenue in Multiple Myeloma Therapy Business (2016-2021)
11.4.5 GlaxoSmithKline plc Recent Development
11.5 F. Hoffmann-La Roche Ltd
11.5.1 F. Hoffmann-La Roche Ltd Company Details
11.5.2 F. Hoffmann-La Roche Ltd Business Overview
11.5.3 F. Hoffmann-La Roche Ltd Multiple Myeloma Therapy Introduction
11.5.4 F. Hoffmann-La Roche Ltd Revenue in Multiple Myeloma Therapy Business (2016-2021)
11.5.5 F. Hoffmann-La Roche Ltd Recent Development
11.6 AbbVie Inc.
11.6.1 AbbVie Inc. Company Details
11.6.2 AbbVie Inc. Business Overview
11.6.3 AbbVie Inc. Multiple Myeloma Therapy Introduction
11.6.4 AbbVie Inc. Revenue in Multiple Myeloma Therapy Business (2016-2021)
11.6.5 AbbVie Inc. Recent Development
11.7 Amgen Inc.
11.7.1 Amgen Inc. Company Details
11.7.2 Amgen Inc. Business Overview
11.7.3 Amgen Inc. Multiple Myeloma Therapy Introduction
11.7.4 Amgen Inc. Revenue in Multiple Myeloma Therapy Business (2016-2021)
11.7.5 Amgen Inc. Recent Development
11.8 Novartis AG
11.8.1 Novartis AG Company Details
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Multiple Myeloma Therapy Introduction
11.8.4 Novartis AG Revenue in Multiple Myeloma Therapy Business (2016-2021)
11.8.5 Novartis AG Recent Development
11.9 Millennium Pharmaceuticals
11.9.1 Millennium Pharmaceuticals Company Details
11.9.2 Millennium Pharmaceuticals Business Overview
11.9.3 Millennium Pharmaceuticals Multiple Myeloma Therapy Introduction
11.9.4 Millennium Pharmaceuticals Revenue in Multiple Myeloma Therapy Business (2016-2021)
11.9.5 Millennium Pharmaceuticals Recent Development
11.10 Innate Pharma SA
11.10.1 Innate Pharma SA Company Details
11.10.2 Innate Pharma SA Business Overview
11.10.3 Innate Pharma SA Multiple Myeloma Therapy Introduction
11.10.4 Innate Pharma SA Revenue in Multiple Myeloma Therapy Business (2016-2021)
11.10.5 Innate Pharma SA Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Multiple Myeloma Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Targeted Therapy
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Radiotherapy
Table 5. Key Players of Bone Marrow Transplant
Table 6. Key Players of Others
Table 7. Global Multiple Myeloma Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Multiple Myeloma Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Multiple Myeloma Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Multiple Myeloma Therapy Market Share by Regions (2016-2021)
Table 11. Global Multiple Myeloma Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Multiple Myeloma Therapy Market Share by Regions (2022-2027)
Table 13. Multiple Myeloma Therapy Market Trends
Table 14. Multiple Myeloma Therapy Market Drivers
Table 15. Multiple Myeloma Therapy Market Challenges
Table 16. Multiple Myeloma Therapy Market Restraints
Table 17. Global Multiple Myeloma Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Multiple Myeloma Therapy Market Share by Players (2016-2021)
Table 19. Global Top Multiple Myeloma Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multiple Myeloma Therapy as of 2020)
Table 20. Ranking of Global Top Multiple Myeloma Therapy Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Multiple Myeloma Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Multiple Myeloma Therapy Product Solution and Service
Table 24. Date of Enter into Multiple Myeloma Therapy Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Multiple Myeloma Therapy Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Multiple Myeloma Therapy Revenue Market Share by Type (2016-2021)
Table 28. Global Multiple Myeloma Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Multiple Myeloma Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Multiple Myeloma Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Multiple Myeloma Therapy Revenue Market Share by Application (2016-2021)
Table 32. Global Multiple Myeloma Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Multiple Myeloma Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Multiple Myeloma Therapy Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Multiple Myeloma Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Multiple Myeloma Therapy Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Multiple Myeloma Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Multiple Myeloma Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Multiple Myeloma Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Multiple Myeloma Therapy Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Multiple Myeloma Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Multiple Myeloma Therapy Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Multiple Myeloma Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Multiple Myeloma Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Multiple Myeloma Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Multiple Myeloma Therapy Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Multiple Myeloma Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Multiple Myeloma Therapy Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Multiple Myeloma Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Multiple Myeloma Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Multiple Myeloma Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Multiple Myeloma Therapy Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Multiple Myeloma Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Multiple Myeloma Therapy Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Multiple Myeloma Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Multiple Myeloma Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Multiple Myeloma Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Multiple Myeloma Therapy Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Multiple Myeloma Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Multiple Myeloma Therapy Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Multiple Myeloma Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Multiple Myeloma Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Multiple Myeloma Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 64. Sanofi Company Details
Table 65. Sanofi Business Overview
Table 66. Sanofi Multiple Myeloma Therapy Product
Table 67. Sanofi Revenue in Multiple Myeloma Therapy Business (2016-2021) & (US$ Million)
Table 68. Sanofi Recent Development
Table 69. Celgene Company Details
Table 70. Celgene Business Overview
Table 71. Celgene Multiple Myeloma Therapy Product
Table 72. Celgene Revenue in Multiple Myeloma Therapy Business (2016-2021) & (US$ Million)
Table 73. Celgene Recent Development
Table 74. Johnson & Johnson Company Details
Table 75. Johnson & Johnson Business Overview
Table 76. Johnson & Johnson Multiple Myeloma Therapy Product
Table 77. Johnson & Johnson Revenue in Multiple Myeloma Therapy Business (2016-2021) & (US$ Million)
Table 78. Johnson & Johnson Recent Development
Table 79. GlaxoSmithKline plc Company Details
Table 80. GlaxoSmithKline plc Business Overview
Table 81. GlaxoSmithKline plc Multiple Myeloma Therapy Product
Table 82. GlaxoSmithKline plc Revenue in Multiple Myeloma Therapy Business (2016-2021) & (US$ Million)
Table 83. GlaxoSmithKline plc Recent Development
Table 84. F. Hoffmann-La Roche Ltd Company Details
Table 85. F. Hoffmann-La Roche Ltd Business Overview
Table 86. F. Hoffmann-La Roche Ltd Multiple Myeloma Therapy Product
Table 87. F. Hoffmann-La Roche Ltd Revenue in Multiple Myeloma Therapy Business (2016-2021) & (US$ Million)
Table 88. F. Hoffmann-La Roche Ltd Recent Development
Table 89. AbbVie Inc. Company Details
Table 90. AbbVie Inc. Business Overview
Table 91. AbbVie Inc. Multiple Myeloma Therapy Product
Table 92. AbbVie Inc. Revenue in Multiple Myeloma Therapy Business (2016-2021) & (US$ Million)
Table 93. AbbVie Inc. Recent Development
Table 94. Amgen Inc. Company Details
Table 95. Amgen Inc. Business Overview
Table 96. Amgen Inc. Multiple Myeloma Therapy Product
Table 97. Amgen Inc. Revenue in Multiple Myeloma Therapy Business (2016-2021) & (US$ Million)
Table 98. Amgen Inc. Recent Development
Table 99. Novartis AG Company Details
Table 100. Novartis AG Business Overview
Table 101. Novartis AG Revenue in Multiple Myeloma Therapy Business (2016-2021) & (US$ Million)
Table 102. Novartis AG Recent Development
Table 103. Millennium Pharmaceuticals Company Details
Table 104. Millennium Pharmaceuticals Business Overview
Table 105. Millennium Pharmaceuticals Multiple Myeloma Therapy Product
Table 106. Millennium Pharmaceuticals Revenue in Multiple Myeloma Therapy Business (2016-2021) & (US$ Million)
Table 107. Millennium Pharmaceuticals Recent Development
Table 108. Innate Pharma SA Company Details
Table 109. Innate Pharma SA Business Overview
Table 110. Innate Pharma SA Multiple Myeloma Therapy Product
Table 111. Innate Pharma SA Revenue in Multiple Myeloma Therapy Business (2016-2021) & (US$ Million)
Table 112. Innate Pharma SA Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Multiple Myeloma Therapy Market Share by Type: 2020 VS 2027
Figure 2. Targeted Therapy Features
Figure 3. Chemotherapy Features
Figure 4. Radiotherapy Features
Figure 5. Bone Marrow Transplant Features
Figure 6. Others Features
Figure 7. Global Multiple Myeloma Therapy Market Share by Application: 2020 VS 2027
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Multiple Myeloma Therapy Report Years Considered
Figure 11. Global Multiple Myeloma Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Multiple Myeloma Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Multiple Myeloma Therapy Market Share by Regions: 2020 VS 2027
Figure 14. Global Multiple Myeloma Therapy Market Share by Regions (2022-2027)
Figure 15. Global Multiple Myeloma Therapy Market Share by Players in 2020
Figure 16. Global Top Multiple Myeloma Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multiple Myeloma Therapy as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Multiple Myeloma Therapy Revenue in 2020
Figure 18. Global Multiple Myeloma Therapy Revenue Market Share by Type (2016-2021)
Figure 19. Global Multiple Myeloma Therapy Revenue Market Share by Type (2022-2027)
Figure 20. North America Multiple Myeloma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Multiple Myeloma Therapy Market Share by Type (2016-2027)
Figure 22. North America Multiple Myeloma Therapy Market Share by Application (2016-2027)
Figure 23. North America Multiple Myeloma Therapy Market Share by Country (2016-2027)
Figure 24. United States Multiple Myeloma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Multiple Myeloma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Multiple Myeloma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Multiple Myeloma Therapy Market Share by Type (2016-2027)
Figure 28. Europe Multiple Myeloma Therapy Market Share by Application (2016-2027)
Figure 29. Europe Multiple Myeloma Therapy Market Share by Country (2016-2027)
Figure 30. Germany Multiple Myeloma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Multiple Myeloma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Multiple Myeloma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Multiple Myeloma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Multiple Myeloma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Multiple Myeloma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Multiple Myeloma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Multiple Myeloma Therapy Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Multiple Myeloma Therapy Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Multiple Myeloma Therapy Market Share by Region (2016-2027)
Figure 40. China Multiple Myeloma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Multiple Myeloma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Multiple Myeloma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Multiple Myeloma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Multiple Myeloma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Multiple Myeloma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Multiple Myeloma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Multiple Myeloma Therapy Market Share by Type (2016-2027)
Figure 48. Latin America Multiple Myeloma Therapy Market Share by Application (2016-2027)
Figure 49. Latin America Multiple Myeloma Therapy Market Share by Country (2016-2027)
Figure 50. Mexico Multiple Myeloma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Multiple Myeloma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Multiple Myeloma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Multiple Myeloma Therapy Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Multiple Myeloma Therapy Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Multiple Myeloma Therapy Market Share by Country (2016-2027)
Figure 56. Turkey Multiple Myeloma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Multiple Myeloma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Multiple Myeloma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Sanofi Revenue Growth Rate in Multiple Myeloma Therapy Business (2016-2021)
Figure 60. Celgene Revenue Growth Rate in Multiple Myeloma Therapy Business (2016-2021)
Figure 61. Johnson & Johnson Revenue Growth Rate in Multiple Myeloma Therapy Business (2016-2021)
Figure 62. GlaxoSmithKline plc Revenue Growth Rate in Multiple Myeloma Therapy Business (2016-2021)
Figure 63. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Multiple Myeloma Therapy Business (2016-2021)
Figure 64. AbbVie Inc. Revenue Growth Rate in Multiple Myeloma Therapy Business (2016-2021)
Figure 65. Amgen Inc. Revenue Growth Rate in Multiple Myeloma Therapy Business (2016-2021)
Figure 66. Novartis AG Revenue Growth Rate in Multiple Myeloma Therapy Business (2016-2021)
Figure 67. Millennium Pharmaceuticals Revenue Growth Rate in Multiple Myeloma Therapy Business (2016-2021)
Figure 68. Innate Pharma SA Revenue Growth Rate in Multiple Myeloma Therapy Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

以下、関連資料のご紹介

世界の多系統萎縮症治療薬市場規模・現状・予測（2021年-2027年）

Global Multiple System Atrophy Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4535 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、多系統萎縮症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アンレ-138b、AZD-3241、CS-10BR05、NPT-20011、PBT-434、PD-01）、用途別市場規模（病院、クリニ...

世界のTIL療法市場規模・現状・予測（2021年-2027年）

Global TIL Therapy Market Size, Status and Forecast 2021-2027
QFJ1-4957 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、TIL療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（単回注入、複数回注入）、用途別市場規模（胃がん、膵臓がん、肝細胞がん、子宮/子宮内膜がん、子宮頸がん、尿道がん、腎細胞がん、その他）、主要地域...

世界の重粒子線治療市場規模・現状・予測（2021年-2027年）

Global Heavy Ion Therapy Market Size, Status and Forecast 2021-2027
QFJ1-5188 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、重粒子線治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（機器、サービス）、用途別市場規模（科学研究所、医療、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界の多発性硬化症薬物治療市場規模・現状・予測（2021年-2027年）

Global Multiple Sclerosis Drugs Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4534 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、多発性硬化症薬物治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（インターフェロン、免疫調節剤、免疫抑制剤）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（北米、...

世界のTCR-T療法試薬市場規模・現状・予測（2021年-2027年）

Global TCR-T Therapy Reagent Market Size, Status and Forecast 2021-2027
QFJ1-4940 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、TCR-T療法試薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（血清試薬、抗体試薬、タンパク質試薬、その他）、用途別市場規模（病院、バイオラボ、その他）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の補助療法市場規模・現状・予測（2021年-2027年）

Global Adjuvant Therapy Market Size, Status and Forecast 2021-2027
QFJ1-3765 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、補助療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、ホルモン療法、その他）、用途別市場規模（病院、医療機関、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の時差ボケ治療薬市場規模・現状・予測（2021年-2027年）

Global Jet Lag Therapy Pharmaceuticals Market Size, Status and Forecast 2021-2027
QFJ1-5816 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、時差ボケ治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（Rx、OTC）、用途別市場規模（ビジネス旅行者、キャビンクルー、アスリート、季節旅行者、その他）、主要地域別市場規模（北米、アメリカ、欧州...

世界の多剤耐性細菌感染症治療市場規模・現状・予測（2021年-2027年）

Global Multiple Drug Resistance Bacterial Infection Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4533 2021年6月 117Pages
QYResearch社発行の本調査レポートでは、多剤耐性細菌感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（クリティカル、ミディアム、ハイ）、用途別市場規模（セファロスポリン、ベータラクタム、ベータラクタマーゼ阻害剤、オキサゾリジノン、環...

世界のパラフィン理学療法市場規模・現状・予測（2021年-2027年）

Global Paraffin Physical Therapy Market Size, Status and Forecast 2021-2027
QFJ1-4653 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、パラフィン理学療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（即時使用可能パラフィン理学療法、即時加熱可能パラフィン理学療法）、用途別市場規模（病院、クリニック、若返りセンター）、主要地域別市場規...

世界の神経再生治療市場規模・現状・予測（2021年-2027年）

Global Neuroregeneration Therapy Market Size, Status and Forecast 2021-2027
QFJ1-4573 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、神経再生治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（末梢神経系の再生、中枢神経系の再生、軸索の再生の阻害）、用途別市場規模（病院、クリニック、研究機関）、主要地域別市場規模（北米、アメリカ、欧...

世界の注射式標的治療市場規模・現状・予測（2021年-2027年） It is at the cellular and molecular level, designed for the treatment of well-defined carcinogenic sites, and designing corresponding therapeutic drugs. When drugs enter the body, they will specifically select carcinogenic sites to combine and act, causing tumor cells to die specifically, without Wi…
世界の血液＆骨髄腫治療市場規模・現状・予測（2021年-2027年） Blood cancer begins in the bone marrow which is the integral source of stem cells which later are differentiated in different types of blood cells in the human body. Market Analysis and Insights: Global Blood and Bone Marrow Cancer Treatment Market The global Blood and Bone Marrow Cancer Treatment m…
世界の小分子標的治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small Molecule Targeted Therapy Market The global Small Molecule Targeted Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data i…
世界の補助療法市場規模・現状・予測（2021年-2027年） Adjuvant therapy is defined as the treatment given in addition to the primary (initial) treatment. In other words it is an additional treatment that is designed to help to reach the ultimate goal. Market Analysis and Insights: Global Adjuvant Therapy Market The global Adjuvant Therapy market size is…
世界のTIL療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global TIL Therapy Market The global TIL Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant a…